New York City Continues Its Campaign To Get School Age Children Vaccinated

Pfizer Vaccine Booster Shows 95.6% Efficacy in Phase 3 Trials as Global Rollout of Additional Shots Continue

Authorities from pharmaceutical company Pfizer and BioNTech revealed that phase 3 trials of their coronavirus vaccine's booster shots showed a 95.6% efficacy. The situation comes as more and more Americans are getting the booster shot to better protect themselves from the infection.
Real Time Analytics